Use access key #2 to skip to page content.
$50.91 -0.03 (-0.06%)
5/16/2008 4:00 PM

LifeCell Corp (LIFC)

CAPS Rating:
****

The Company develops and markets tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.

View All Commentary (LIFC)

Recs

1

Avatar tenmiles (99.90) Submitted: 9/12/07 10:39 AM : Underperform Start Price: $35.43 LIFC Score: -47.29

Good company with a growing market within the tissue graft area, but current $35.13 price at 40x earnings discounts almost all of the upside in the near term. Technically, probably only a point or two upside exposure (absent a takeover or some extradinary event); technical retracement to $32 range highly likely within next few months.

Report this Post Replies: 0 | Reply

Featured Broker Partners